Free Republic

Booster shot effectiveness against the Omicron coronavirus variant wanes faster than it does against Delta, according to new data collected in the United Kingdom. The data shows the booster vaccines’ protection against Omicron drops significantly after about 10 weeks. In a report published Thursday, the UK Health Security Agency released data on 147,597 Delta and 68,489 Omicron cases, using the country’s vaccination information to assess the longevity of the AstraZeneca, Pfizer, and Moderna vaccines and boosters. Every vaccine was less effective against Omicron than Delta over time, but to varying degrees, per the agency’s analysis. For those who received two...

The study, which has not been peer-reviewed, found that people who were infected with Omicron, especially those who were vaccinated, developed enhanced immunity to the Delta variant. The analysis enrolled 33 vaccinated and unvaccinated people who were infected with the Omicron variant in South Africa.

The CEO of BioNtech, which produces what most refer to as the “Pfizer shot,” (Pfizer is BioNtech’s Western partner and is primarily responsible for the logistics, delivery, and marketing related to the mRNA shots) stated Wednesday that the company intends on selling a three-dose regimen for the Omicron variant of the coronavirus. Citing “the data coming from the Omicron variant, BioNtech CEO Ugur Sahin stated: “It is very clear our vaccine for the Omicron variant should be a three dose vaccine.” JUST IN – BioNTech CEO: Potentially upcoming vaccine for the #Omicron variant "should be a 3-dose vaccine." pic.twitter.com/ounAm4Fd41 —...